Aktie A2PH4R LEXINGTON BIOSCIENCES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Lexington Biosciences, Inc. Canadian Securities Exchange

Aktien

A2PH4R

CA5290204067

LNB

Verzögert Canadian Securities Exchange
Andere Börsenplätze
 		% 5 Tage % 1. Jan.
- CAD -.--% Intraday Chart für Lexington Biosciences, Inc. +6.67% +166.67%
01.05. Registered Plan Private Investments Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Registered Plan Private Investments Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Registered Plan Private Investments Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Registered Plan Private Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Registered Plan Private Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Registered Plan Private Investments Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Registered Plan Private Investments Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Registered Plan Private Investments Inc. Auditor Raises 'Going Concern' Doubt
Registered Plan Private Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Registered Plan Private Investments Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Registered Plan Private Investments Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Registered Plan Private Investments Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Registered Plan Private Investments Inc. Auditor Raises 'Going Concern' Doubt
Registered Plan Private Investments Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Registered Plan Private Investments Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Registered Plan Private Investments Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
Lexington Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
Lexington Biosciences, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
Lexington Biosciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020
Lexington Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020
Lexington Biosciences, Inc. Approves the Election of Tamara Manuel as Director
Lexington Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PH4R Aktie
  4. A2PH4R Aktie
  5. Nachrichten Lexington Biosciences, Inc.
  6. Andere Sprachen